Antipsychotic drugs antagonise human serotonin type 3 (5-HT3) receptor currents in a noncompetitive manner

Molecular Psychiatry

Volumn 9, Issue 9, 2004, Pages 818-

  Rammes, G ^a   Eisensamer, B ^a,b   Ferrari, U ^a   Shapa, M ^b   Gimpl, G ^c   Gilling, K ^d   Parsons, C ^d   Riering, K ^a,b   Hapfelmeier, G ^a,e   Bondy, B ^b   Zieglgansberger W ^a   Holsboer, F ^a   Rupprecht, R ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d MERZ PHARMACEUTICALS GMBH   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN 3 RECEPTOR; THIORIDAZINE;

ARTICLE; DRUG EFFICACY; DRUG RECEPTOR BINDING; EVOKED RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SODIUM CURRENT;

EID: 4644345177     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001567     Document Type: Article

References (0)